These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 12048910
41. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ. AJR Am J Roentgenol; 2004 Aug; 183(2):283-9. PubMed ID: 15269013 [Abstract] [Full Text] [Related]
42. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings. Tomiyama N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, Hamada S, Okumura M, Ohta M, Eimoto T, Miyagawa M, Müller NL, Ikezoe J, Nakamura H. AJR Am J Roentgenol; 2002 Oct; 179(4):881-6. PubMed ID: 12239030 [Abstract] [Full Text] [Related]
44. Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma. Safieddine N, Liu G, Cuningham K, Ming T, Hwang D, Brade A, Bezjak A, Fischer S, Xu W, Azad S, Cypel M, Darling G, Yasufuku K, Pierre A, de Perrot M, Waddell T, Keshavjee S. J Thorac Oncol; 2014 Jul; 9(7):1018-1022. PubMed ID: 24926546 [Abstract] [Full Text] [Related]
46. Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors. Meurgey A, Girard N, Merveilleux du Vignaux C, Maury JM, Tronc F, Thivolet-Bejui F, Chalabreysse L. J Thorac Oncol; 2017 Oct; 12(10):1571-1581. PubMed ID: 28694035 [Abstract] [Full Text] [Related]
47. Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome. Tateyama H, Sugiura H, Yamatani C, Yano M. Hum Pathol; 2011 Apr; 42(4):533-40. PubMed ID: 21237498 [Abstract] [Full Text] [Related]
56. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M. Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867 [Abstract] [Full Text] [Related]
58. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas. Roden AC, Yi ES, Jenkins SM, Donovan JL, Cassivi SD, Garces YI, Marks RS, Aubry MC. Hum Pathol; 2015 Jan; 46(1):17-25. PubMed ID: 25455993 [Abstract] [Full Text] [Related]
59. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3? Laeng RH, Eimoto T, Kuo TT, Zettl A, Marx A, Moschopulos M, Tateyama H, Shimokawa K. Pathol Res Pract; 2006 Jan; 202(10):697-704. PubMed ID: 16887284 [Abstract] [Full Text] [Related]
60. World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Marchevsky AM, Gupta R, Casadio C, Hiroshima K, Jambhekar NA, Kim DJ, Nakatani Y, Okumura M, Rena O, Yoshida S. Hum Pathol; 2010 Oct; 41(10):1413-21. PubMed ID: 20573368 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]